Vaxcyte (PCVX) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Vaxcyte insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $12.4M of PCVX stock on the open market.
Get emailed when insiders cluster-buy stocks like PCVX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PCVX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $3.3M | 4 |
| Q3 2026 | — | 0 | $3.7M | 22 |
| Q2 2026 | — | 0 | $3.7M | 20 |
| Q1 2026 | — | 0 | $687K | 5 |
| Q4 2025 | — | 0 | $1.0M | 3 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Vaxcyte, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $12.4M. 51 of 54 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 7SEC | Elvia CowanSvp, Finance & Cao | Sell Plan | 19,00027,860 held (−41%) | $86.74 | $1.6M | -17.7% | — |
| Oct 7SEC | Jim WassilCOO | Sell Plan | 18,000145,435 held (−11%) | $86.74 | $1.6M | -17.7% | — |
| Oct 2SEC | Jim WassilCOO | Sell Plan | 2,155145,530 held (−1%) | $56.65 | $122K | +26.0% | — |
| Oct 2SEC | Jim WassilCOO | Sell Plan | 95145,435 held (−0%) | $57.09 | $5K | +25.0% | — |
| Sep 9SEC | Jim WassilCOO | Sell Plan | 1,381152,228 held (−1%) | $61.16 | $84K | +16.7% | — |
| Sep 9SEC | Jim WassilCOO | Sell Plan | 1,334145,435 held (−1%) | $59.52 | $79K | +19.9% | — |
| Sep 2SEC | Jim WassilCOO | Sell Plan | 1,537156,981 held (−1%) | $60.89 | $94K | +17.2% | — |
| Sep 2SEC | Jim WassilCOO | Sell Plan | 924155,344 held (−1%) | $60.96 | $56K | +17.1% | — |
| Sep 2SEC | Jim WassilCOO | Sell Plan | 713156,268 held (−0%) | $61.48 | $44K | +16.1% | — |
| Sep 2SEC | Jim WassilCOO | Sell Plan | 303155,041 held (−0%) | $61.42 | $19K | +16.2% | — |
| Aug 5SEC | Harpreet S. DhaliwalChief Technical Ops Officer | Sell Plan | 17,00076,756 held (−18%) | $55.00 | $935K | +29.8% | — |
| Aug 5SEC | Andrew GuggenhimeCFO, President | Sell Plan | 6,956108,220 held (−6%) | $53.76 | $374K | +32.8% | — |
| Aug 5SEC | Andrew GuggenhimeCFO, President | Sell Plan | 3,044105,176 held (−3%) | $54.18 | $165K | +31.7% | — |
| Aug 5SEC | Jim WassilCOO | Sell Plan | 1,389157,541 held (−1%) | $54.09 | $75K | +32.0% | — |
| Aug 5SEC | Jim WassilCOO | Sell Plan | 861158,930 held (−1%) | $53.50 | $46K | +33.4% | — |
| Jul 28SEC | Grant PickeringCEO | Sell Plan | 11,783457,662 held (−3%) | $55.52 | $654K | +28.6% | — |
| Jul 28SEC | Grant PickeringCEO | Sell Plan | 4,415453,247 held (−1%) | $55.93 | $247K | +27.6% | — |
| Jul 28SEC | Grant PickeringCEO | Sell Plan | 756133,459 held (−1%) | $55.52 | $42K | +28.6% | — |
| Jul 28SEC | Grant PickeringCEO | Sell Plan | 622133,593 held (−0%) | $55.54 | $35K | +28.5% | — |
| Jul 28SEC | Grant PickeringCEO | Sell Plan | 378133,215 held (−0%) | $55.91 | $21K | +27.7% | — |
| Jul 28SEC | Grant PickeringCEO | Sell Plan | 244133,215 held (−0%) | $55.96 | $14K | +27.6% | — |
| Jul 6SEC | Andrew GuggenhimeCFO, President | Sell Plan | 7,913106,482 held (−7%) | $57.16 | $452K | +24.9% | — |
| Jul 6SEC | Andrew GuggenhimeCFO, President | Sell Plan | 2,087104,395 held (−2%) | $57.76 | $121K | +23.6% | — |
| Jul 6SEC | Jim WassilCOO | Sell Plan | 1,788157,222 held (−1%) | $56.03 | $100K | +27.4% | — |
| Jul 6SEC | Jim WassilCOO | Sell Plan | 456156,766 held (−0%) | $57.47 | $26K | +24.2% | — |
| Jul 6SEC | Jim WassilCOO | Sell Plan | 6156,760 held (−0%) | $57.82 | $347 | +23.5% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 9,137458,883 held (−2%) | $55.27 | $505K | +29.1% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 6,683468,020 held (−1%) | $54.28 | $363K | +31.5% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 6,417452,466 held (−1%) | $56.12 | $360K | +27.2% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 602134,406 held (−0%) | $55.30 | $33K | +29.1% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 356134,547 held (−0%) | $55.23 | $20K | +29.2% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 332134,215 held (−0%) | $55.99 | $19K | +27.5% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 312134,903 held (−0%) | $54.35 | $17K | +31.3% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 207135,008 held (−0%) | $54.22 | $11K | +31.6% | — |
| Jun 26SEC | Grant PickeringCEO | Sell Plan | 191134,215 held (−0%) | $56.27 | $11K | +26.9% | — |
| Jun 18SEC | Grant PickeringCEO | Sell Plan | 22,236474,703 held (−4%) | $52.50 | $1.2M | +36.0% | — |
| Jun 18SEC | Andrew GuggenhimeCFO, President | Sell Plan | 10,000104,395 held (−9%) | $53.00 | $530K | +34.7% | — |
| Jun 18SEC | Grant PickeringCEO | Sell Plan | 1,000135,215 held (−1%) | $52.50 | $52K | +36.0% | — |
| Jun 18SEC | Grant PickeringCEO | Sell Plan | 1,000135,215 held (−1%) | $52.50 | $52K | +36.0% | — |
| Jun 18SEC | Grant PickeringCEO | Sell Plan | 225496,939 held (−0%) | $52.51 | $12K | +35.9% | — |
| Jun 3SEC | Jim WassilCOO | Sell Plan | 1,949158,795 held (−1%) | $49.40 | $96K | +44.5% | — |
| Jun 3SEC | Jim WassilCOO | Sell Plan | 301158,494 held (−0%) | $50.26 | $15K | +42.0% | — |
| May 1SEC | Jim WassilCOO | Sell Plan | 2,250160,744 held (−1%) | $56.83 | $128K | +25.6% | — |
| Apr 8SEC | Elvia CowanSvp, Finance & Cao | Sell Plan | 3,00028,975 held (−9%) | $60.00 | $180K | +19.0% | — |
| Apr 3SEC | Jim WassilCOO | Sell Plan | 1,412165,406 held (−1%) | $58.14 | $82K | +22.8% | — |
| Apr 3SEC | Jim WassilCOO | Sell Plan | 838162,994 held (−1%) | $58.93 | $49K | +21.1% | — |
| Mar 18SEC | Elvia CowanSvp, Finance & Cao | Sell Plan | 1,48729,380 held (−5%) | $55.39 | $82K | +28.9% | — |
| Mar 18SEC | Elvia CowanSvp, Finance & Cao | Sell Plan | 40528,975 held (−1%) | $56.26 | $23K | +26.9% | — |
| Mar 11SEC | Jim WassilCOO | Sell Plan | 4,968166,818 held (−3%) | $59.16 | $294K | +20.7% | — |
| Mar 11SEC | Elvia CowanSvp, Finance & Cao | Sell Plan | 2,50030,867 held (−7%) | $58.59 | $146K | +21.8% | — |
| Mar 11SEC | Jim WassilCOO | Sell Plan | 2,427171,786 held (−1%) | $58.32 | $142K | +22.4% | — |
| Jan 2SEC | Harpreet S. DhaliwalChief Technical Ops Officer | Sell | 9,74323,928 held (−29%) | $46.69 | $455K | +52.9% | — |
| Dec 29SEC | Elvia CowanSvp, Finance | Sell | 6,71614,534 held (−32%) | $47.94 | $322K | +48.9% | — |
| Dec 29SEC | Elvia CowanSvp, Finance | Sell | 4,90721,250 held (−19%) | $47.90 | $235K | +49.0% | — |
Insiders at Vaxcyte, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Grant PickeringCEO | — | $3.6M | Jul 28, 2026 | — |
| Jim WassilCOO | — | $3.1M | Oct 7, 2026 | — |
| Elvia CowanSvp, Finance & Cao | — | $2.6M | Oct 7, 2026 | — |
| Andrew GuggenhimeCFO, President | — | $1.6M | Aug 5, 2026 | — |
| Harpreet S. DhaliwalChief Technical Ops Officer | — | $1.4M | Aug 5, 2026 | — |
PCVX stock: common questions
Are Vaxcyte, Inc. insiders buying PCVX stock?
In the past 12 months, 0 insiders reported open-market purchases of PCVX worth $0.
Are Vaxcyte, Inc. insiders selling PCVX stock?
5 insiders reported sales worth $12.4M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PCVX's 52-week range?
Over the past year PCVX has traded between $40.32 and $73.82. It last closed at $71.38 on Oct 9, 2026.